Finance

Beta
Ask
Lists
PUR:WSE
Pure Biologics SA
PLN 2.16
-1.82%
(-0.040) 1D
Jun 12, 5:00:01 PM GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for PUR...
Open
PLN 2.32
High
PLN 2.33
Low
PLN 2.12
Mkt. cap
26.45M
Avg. vol.
210.59K
Volume
153.79K
52-wk high
PLN 6.63
52-wk low
PLN 1.35
Shares outstanding
12.24M
No. of employees
7
Open
PLN 2.32
High
PLN 2.33
Low
PLN 2.12
Mkt. cap
26.45M
Avg. vol.
210.59K
Volume
153.79K
52-wk high
PLN 6.63
52-wk low
PLN 1.35
Shares outstanding
12.24M
No. of employees
7
News stories
From sources across the web
About Pure Biologics SA
CEO-
Employees7
Founded2010
Headquarters-
SectorBiotechnology
Websitepurebiologics.com
Previous reportsAll values in PLN
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in PLN
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
8.00K
5.00K
9.00K
334.00K
Cost of revenue
8.00K
5.00K
9.00K
334.00K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.12M
1.27M
665.00K
1.23M
Operating expense
2.26M
900.00K
1.32M
1.36M
Total operating expenses
2.27M
905.00K
1.33M
1.70M
Operating income
-2.27M
-905.00K
-1.33M
-1.70M
Other non operating income
-1.00K
-28.00K
-11.00K
1.00K
EBT including unusual items
-3.02M
-1.30M
-2.42M
-2.36M
EBT excluding unusual items
-2.59M
-1.30M
-2.42M
-2.36M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-960.00K
-422.00K
704.00K
131.00K
Net income
-4.72M
-1.22M
-2.55M
-2.24M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
30.00K
-
-
-
Interest expense
-470.00K
-364.00K
-1.17M
-666.00K
Net interest expenses
-440.00K
-364.00K
-1.17M
-666.00K
Depreciation and amortization charges
96.00K
54.00K
-44.00K
-
EBITDA
-2.23M
-870.00K
-1.32M
-1.67M
Gain or loss from assets sale
-1.00K
-6.00K
-297.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer